Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LEVP2005-1/Part A: A Double-blind, Placebo-Controlled, Clinical Study to Investigate the Efficacy and Safety of Purified C1 Esterase Inhibitor (Human) for the Treatment of HAE in Acute Attacks

NCT00289211 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00289211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00289211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LEVP2005-1/Part A: A Double-blind, Placebo-Controlled, Clinical Study to Investigate the Efficacy and Safety of Purified C1 Esterase Inhibitor (Human) for the Treatment of HAE in Acute Attacks
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
March 14, 2005
Completion date
April 13, 2007
Enrollment
83 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema